Respiratory distress syndrome in the newborn

dc.contributor.authorAslan, Mustafa Törehan
dc.date.accessioned2024-10-29T17:43:50Z
dc.date.available2024-10-29T17:43:50Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractRespiratory distress syndrome (RDS) is one of the most common main causes of respiratory failure, especially in very preterm newborns. Atelectasis results from a surfactant deficiency resulting in lung injury due to increased ventilation-perfusion mismatch and a marked pulmonary inflammatory response. The key intervention to prevent RDS, particularly for preterm delivery <34 weeks of gestation, is the administration of antenatal corticosteroid therapy in high-risk pregnant women. Maintaining body temperature after birth, proper ventilation, surfactant treatment, fluid, and perfusion, etc. Optimal treatment management, such as the delivery room, is very important and critical along with appropriate care services. © 2023 Nova Science Publishers, Inc. All rights reserved.
dc.identifier.endpage181
dc.identifier.isbn979-888697714-1
dc.identifier.isbn979-888697545-1
dc.identifier.scopus2-s2.0-85159920511
dc.identifier.startpage169
dc.identifier.urihttps://hdl.handle.net/20.500.11776/12646
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherNova Science Publishers, Inc.
dc.relation.ispartofCurrent Topics in Perinatology and Neonatology
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeonates
dc.subjectPrematurity
dc.subjectRespiratory distress syndrome (RDS)
dc.subjectSurfactant
dc.titleRespiratory distress syndrome in the newborn
dc.typeBook Chapter

Dosyalar